sur NOVACYT (EPA:ALNOV)
Novacyt Announces the Publication of its 2025 Financial Results
Novacyt SA, a molecular diagnostics company, announced that it will publish its audited financial results for 2025 on April 30, 2026. The results presentation will be accompanied by a webinar hosted by Chief Executive Officer Lyn Rees and Chief Financial Officer Steve Gibson. This session for investors will be followed by a Q&A session on the same day at 11:00 GMT. Interested parties can submit their questions in advance and will have access to French subtitles during the presentation.
In addition, a video has been recorded by management to discuss the recent acquisition of Southern Cross Diagnostics Pty Ltd and the associated capital increase. The details of the acquisition and its strategic implications for the company are explained by management in this online video.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de NOVACYT